Blue Horseshoe Stocks: Closing Out Big Week

Arcadia Biosciences, Inc.  RKDA

We tagged RKDA for the first time since May in our extended watchlist yesterday morning, and we were met with a fantastic intraday rip. The stock traded up from a low of 6.93 and managed an intraday high of 10.40 before tapering back into the close. Daytraders could have made a pass at gains of up to 50%

That represents 8-month highs for the stock, a feat which was made possible by the company’s entry into the cannabis space. RKDA will hire a number of agricultural scientists/geneticists to develop ideal strains of hemp. It’s a story we’ll definitely want to follow.


Fresh Options Ideas

We’d like to close out this trading week by once again selecting a group of fresh options ideas to watch today.

Puma Biotech, Inc. PBYI Weekly $33.50-36 Calls*
Foot Locker, Inc. FL Weekly $65-68 Calls*
SPLK Weekly $141-144 Calls*
FNKO 03/15 $22-25 Calls

*Please do not attempt to trade weekly options on a Friday if you are not a seasoned vet trader with disposable funds.


Extended Watchlist:
FLKS, CPRI, PTLA, FOMX, FNKO, OMER, HABT, LXRX, NVCN, CIFS

Blue Horseshoe Stocks: GSK Recap & More

GlaxoSmithKline plc GSK – Update

We attempted to keep our excellent 2019 options performance intact yesterday, and we did see some chances for intraday gains in the fresh idea for GSK we included in our premarket report.

The stock didn’t skyrocket by any means, rising by less than a dollar, but the activity was sufficient to produce the following moves in our designated contracts.

$39.50 Calls – Range: .65-1.24 – Max Gain: 91%
$40 Calls – Range: .15-.75 – Max Gain: 400%
$40.50 Calls – Range: .10-.40 – Max Gain: 300%
_____

Fresh Idea:
GRUB Weekly $86-87.50 Calls


Calix, Inc. CALX &
Vanda Pharmaceuticals, Inc. VNDA

We want to group these two stocks together this morning and tag them as bottom-watch plays. We’ll observe for the establishment of higher lows after their recent selloffs.

Both are now in the position of being extremely oversold, and exhibiting many of the conditions we routinely look for in potential recovery plays. We’ll observe their activity as we head into the end of the week.


Extended Watchlist:
DRVD, PYDS, NVCN, TPNL, BIOC

Blue Horseshoe Stocks: RARX Review & More

Ra Pharmaceuticals. Inc. RARX

It was the morning of December 12th that we most recently highlighted RARX, and it is one stock that has weathered the ups and downs of the past few weeks quite well. In fact, subsequent to that report, we’ve observed a run from a low of 15.23, up as high as 22.15. That amounts to a run of 45% which is highly respectable for a $15+ stock over a short time span.

That high also represented a new 52-week high for the stock, which is especially impressive when you consider that most stocks out there are just now coming off of recently established annual lows. We’ll be highly interested to see if RARX can continue to push its upper limits.

For what it’s worth, our first-ever mention of RARX came last February, when it was trading at less than $6/share.


Petroleo Brasileiro SA (Petrobras) PBR

We’ve got a long history with PBR options that stretches back years, as you can see in our PBR Archive. Like a lot of other stocks we’re seeing, PBR is coming off of recent relative lows, and has gained a quick boost from the loosening pressure on the markets over the past week.

PBR has breached its 50-day moving average in the premarket, and we want to line up a pair of quick-strike options trading possibilities to correspond with this volatile activity. We’ll be watching the PBR Weekly $14 & 14.50 Calls.


Extended Watchlist:
ICON, SBS, MYSZ, NVCN, APDN, BTAI, VLRX, IMMR

Blue Horseshoe Stocks: YGYI Review & More

Youngevity International Inc. YGYI – Recap

Last Thursday morning, we included a tag of YGYI, and today we wanted to swing back around and update readers on the stock’s performance.

YGYI ended up producing a significant dip-and-rip opportunity, coming down to an even 6.00 low before taking off and hitting a high of 10.95 yesterday, in one of its biggest single-session moves of all time. It worked out to an 83% upswing. and put YGYI in blue skies, not to mention grabbing it the top gainer spot on the whole of the NASDAQ.



eBay, Inc.  EBAY – Update

We also want to circle around for the extended term options plays we selected for observation, also in last Thursday’s report. Those were the EBAY 11/23 $33-35 Calls, and they’ve gotten off to a good start for us so far. In the four sessions since we highlighted these plays, all three have produce gains of a significant nature:

$33 Puts – Range: 1.22-2.45 – Max Gain: 101%
$34 Puts – Range: .82-1.75 - Max Gain: 113%
$35 Puts – Range: .60-.86 - Max Gain: 43%

With tons of time remaining until expiration, we’ll be eager to continue tracking these ideas for further moves.


Extended Watchlist: 
ADOM, IGC, NBEV, BLRX, NVCN, RARX

Blue Horseshoe Stocks: HOME Recap & More

Alibaba Group Holding Ltd. BABA – Options Idea

We’d like to start things off this morning by taking a look at BABA, which recently has formed a strong double-bottom setup on the chart. The stock is gapping up in premarket trading today, currently in the mid-$170′s and we’d like to formulate an extended term options idea to track over the next few weeks for an overdue recovery.

We’re going to zero in on the BABA 05/04 $180-187.50 Calls, which will give us plenty of time for the stock to realize the kind of gains that look very possible from a technical standpoint at this juncture.


At Home Group, Inc. HOME – Update

On the morning of March 23rd, we had selected a longer-term idea for the HOME options chain, and we wanted to take a look at the moves it has made in the three and a half weeks since that time.

Our target set of contracts was the HOME 04/20 $30 Calls, and with the stock surging to nearly $35 this week, those calls have been pushed well into the money and produced a heck of a gain opportunity. From the low shortly after our initial alert to a new high reach yesterday, we’ve seen a run from 1.31-5.50, which represents a chance at profits of up to 320%


Extended Watchlist:
ATRA, DQ, CHFS, RSLS, NVCN, HEAR